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Environmental enteric dysfunction is a common but poorly
understood disorder associated with early childhood
malnutrition. In this review, we appraise the application of
murine models to advance understanding of how specific
intestinal microbes contribute to the development of envi-
ronmental enteric dysfunction.
Environmental enteric dysfunction (EED) (also referred to
as environmental enteropathy) is a subclinical chronic
intestinal disorder that is an emerging contributor to
early childhood malnutrition. EED is common in
resource-limited settings, and is postulated to consist of
small intestinal injury, dysfunctional nutrient absorption,
and chronic inflammation that results in impaired early
child growth attainment. Although there is emerging
interest in the hypothetical potential for chemical toxins
in the environmental exposome to contribute to EED, the
propensity of published data, and hence the focus of this
review, implicates a critical role of environmental mi-
crobes. Early childhood malnutrition and EED are most
prevalent in resource-limited settings where food is
limited, and inadequate access to clean water and
sanitation results in frequent gastrointestinal pathogen
exposures. Even as overt diarrhea rates in these settings
decline, silent enteric infections and faltering growth
persist. Furthermore, beyond restricted physical
growth, EED and/or enteric pathogens also associate
with impaired oral vaccine responses, impaired cogni-
tive development, and may even accelerate metabolic
syndrome and its cardiovascular consequences. As these
potentially costly long-term consequences of early
childhood enteric infections increasingly are appreci-
ated, novel therapeutic strategies that reverse damage
resulting from nutritional deficiencies and microbial
insults in the developing small intestine are needed.
Given the inherent limitations in investigating how spe-
cific intestinal pathogens directly injure the small
intestine in children, animal models provide an afford-
able and controlled opportunity to elucidate causal
sequelae of specific enteric infections, to differentiate
consequences of defined nutrient deprivation alone from
co-incident enteropathogen insults, and to correlate the
resulting gut pathologies with their functional impact
during vulnerable early life windows. (Cell MolGastroenterol Hepatol 2019;7:692–707; https://doi.org/
10.1016/j.jcmgh.2018.12.006)
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nvironmental enteric dysfunction (EED; also knownEas environmental enteropathy [EE]) is a subclinical
chronic intestinal disorder that is an emerging contributor
to early childhood malnutrition.1 EED is common in
resource-limited settings, and is postulated to consist of
small intestinal injury, dysfunctional nutrient absorption,
and chronic inflammation that results in impaired early
child growth attainment.1–5 Although there is emerging
interest in the hypothetical potential for chemical toxins in
the environmental exposome to contribute to EED,6–8 the
propensity of published data, and hence the focus of this
review, implicates a critical role of environmental microbes.
Early childhood malnutrition and EED are most prevalent in
resource-limited settings where food is limited, and inade-
quate access to clean water and sanitation results in
frequent gastrointestinal pathogen exposures.9–11 Even as
overt diarrhea rates in these settings decline, “silent“ enteric
infections and faltering growth persist.12,13 Furthermore,
beyond restricted physical growth (decrease in height for
age z-score [HAZdrop]),14 EED and/or enteric pathogens
also associate with impaired oral vaccine responses,15
impaired cognitive development (cognitive impairment
hit),16 and may even accelerate metabolic syndrome and its
cardiovascular consequences.17,18 As these potentially
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infections increasingly are appreciated, novel therapeutic
strategies that reverse damage resulting from nutritional
deficiencies and microbial insults in the developing small
intestine are needed. Given the inherent limitations in
investigating how specific intestinal pathogens directly
injure the small intestine in children, animal models provide
an affordable and controlled opportunity to elucidate causal
sequelae of specific enteric infections, to differentiate con-
sequences of defined nutrient deprivation alone from
co-incident enteropathogen insults, and to correlate the
resulting gut pathologies with their functional impact during
vulnerable early life windows.
Definition of EED
Despite coordinated global efforts to improve the nutri-
tional status of malnourished children, the protein-rich
complementary foods combined with vitamin A and zinc
supplementation, breastfeeding promotion, and prenatal
micronutrient supplementation are predicted to decrease
global linear growth restriction (stunting) by only a third.19
The lackluster outcomes of these interventions have led to a
resurgence in epidemiologic and pathogenesis research
focused on what factors drive and sustain malnutrition.
The concept that childhoodmalnutrition is caused not only
by nutrient depravation, but is at least in part a result of un-
derlying intestinal dysfunction, has been evolving for more
than50years. In the 1960s, small intestinal villousflattening20
was first observed in children with kwashiorkor-type (protein
energy) malnutrition.1 A decade later, similar structural pa-
thologies were observed in North American Peace Corps vol-
unteers during their service, and these abnormalities
recovered upon repatriation.21 Subsequently, it was recog-
nized that many children across geographically widespread
resource-limited settings also show markers of intestinal
inflammation (eg, fecal neopterin and fecal myeloperoxidase
[fMPO]).22 These inflammatory markers that are otherwise
uncommon in children in resource-abundant settings are
associated with growth shortfalls as well as small intestinal
villus blunting, and/or increased intestinal permeability. More
recently, stunting in these children also was associated with
increased serum inflammatorymarkers (eg, C-reactive protein
[CRP] and a1-acid glycoprotein [AGP]).23–25 Several other al-
terations in the intestinal microbiome, other biomarkers of
intestinal inflammation, and metabolic perturbations have
since been associatedwith poor growth. The term EED is used
to describe these clusters of findings suggestive of impaired
gut function with clear geographic associations. Although a
consensus definition of EE/EED is still in progress,1 our use of
EE throughout this review therefore is meant to include both
pathophysiology2 and pathological function that is also
referred to as EED.3
EED Knowledge Gaps
Unlike other small intestinal inflammatory disorders,
such as gluten-sensitive enteropathy, no single-culprit
environmental factor has been identified as a cause of
EED. Although there is emerging interest in the hypotheticalpotential for chemical toxins in the environmental expo-
some to contribute to EED,6–8 the propensity of published
data, and hence the focus of this review, implicates a critical
role of environmental microbes. In addition to diminished
nutrient availability, precedent and recurrent episodes of
infectious diarrhea also associate with childhood growth
restriction.6,26 Even as diarrhea incidence and severity has
decreased since the 1960s, approximately 500,000 global
childhood deaths annually remain attributed to enteric in-
fections.14 Likewise, the rates of stunting have been rela-
tively stagnant. Emerging evidence from global studies in
birth cohorts now show that cumulative,
silent enteropathogen exposures, even in the absence of
diarrhea, are associated with childhood stunting10,11 and/or
altered intestinal permeability.10,27 Specific pathogens (such
as norovirus, Campylobacter species, heat-labile toxin (LT)-
enterotoxigenic Escherichia coli (ETEC), Shigella, Giardia,
and Cryptosporidium among others) are associated inde-
pendently with growth restriction, however, no single
microbe has been identified as solely responsible for EED.
Current epidemiologic findings have suggested that EED
results from the convergence of nutrient deficiencies and
multiple co-pathogens, potentially operating through
distinct pathways. How quantitative pathogen-attributable
burden influences growth restriction severity and vari-
ability across geographic sites and ages28,29 requires further
study.28 These analyses will help to clarify whether and to
what extent specific pathogens likely operate through EED
or EED-like pathways to promote malnutrition.
The outcomes of recent trials support the need for a
deeper understanding of how subclinical intestinal path-
ogen exposures may contribute to intestinal dysfunction.
Rejuvenating intestinal epithelial cells through nutrient-
based remedies may be only transiently beneficial.30
Micronutrient supplementation31 or just zinc,32 can
partially improve permeability (as measured by lactulose:
mannitol [L:M] ratios), but not to normal/healthy values.
Alanyl-glutamine, a fuel for epithelial cells, also improves
permeability as well as child weight, but does not promote
linear growth.33 One explanation for this limited benefit
could be ongoing damage from intestinal inflammation.
Targeting intestinal inflammation with mesalamine, how-
ever, did not promote growth in children with severe acute
malnutrition, despite evidence of diminished systemic
inflammation.34 Ongoing insults from intestinal pathogens
could limit either nutrient- or anti-inflammatory–based
therapies. Knowledge gaps remain, however, in our under-
standing of which microbes are most relevant for EED.35
Antibacterial therapy also has led to mixed results. Either
amoxicillin or cefdinir decreased mortality and accelerated
recovery among children with severe acute malnutrition,36
however, in a separate study amoxicillin had no apparent
benefit in children with less severe malnutrition.37 The
luminal agent rifaximin did not improve L:M ratios 3 weeks
after treatment.38 Targeting intestinal parasites, such as
Giardia, also had little effect on stunting or intestinal
permeability, and Giardia re-infection was rapid.39 Compli-
cating these findings, multiple and often nonprescription
courses of broadly active antibiotics are common in many
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weight gain, unsupervised antimicrobials do not appear to
decrease stunting.41 Even when combined as a triple-
therapy intervention of micronutrients plus zinc plus
albendazole, neither linear growth attainment nor bio-
markers of EED improved.42 Probiotic approaches have
shown safety but have yet to establish efficacy for promot-
ing growth or reducing diarrhea in these children.43 Finally,
despite clear associations between environmental soil and
fecal contamination and malnutrition, interventions to
improve water, sanitation, and hygiene (without improved
public sewage and water systems44) have resulted in only a
small, if any, ability to reduce stunting at the population
level.45 Thus, a better understanding of how hosts and
specific microbes adapt to select nutritional deficiencies
and how these microbial interactions shape host intestinal
function, inflammation, metabolism, and growth is needed.
Translating EED and EED-Like
Conditions in Mice
Mucosal and Functional Correlates of EED in
Children
Emerging findings from comprehensive longitudinal
analyses of children with poor growth are formulating
clearer, if not highly complex and multifaceted interactions,
between functional impairments, small intestinal pathology,
microbial influences, biomarkers, and metabolic profile per-
turbations associated with EED (Supplementary Table 1).
Characteristic upper small intestinal histopathologic features
of EED overlap with, but also are distinct from, other chronic
small intestinal enteropathies such as gluten-sensitive en-
teropathy and inflammatory bowel diseases. EED can show
villous atrophy often with crypt hyperplasia,20,46 epithelial
barrier disruption47 corresponding to altered small intestinal
permeability, 35,38,48–50 and aberrations in tight-junction (TJ)
proteins. Subepithelial features include lymphocyte infiltra-
tion into the lamina propria20,46,51,52 comprising B cells and
activated T cells,46 local immune dysregulation,53,54 and
increased interferon g (IFNg) with relatively reduced inter-
leukin (IL)10.49
Given that direct examination of upper small intestinal
pathology in children with EED is seldom performed, func-
tional and trackable markers relating impaired growth with
intestinal barrier function, mucosal inflammation, and sys-
temic inflammation are used in birth cohort studies.
Increased intestinal permeability frequently is used as a
marker of intestinal dysfunction. Intestinal permeability
often is measured comparing absorption of the sugar
alcohol mannitol with the otherwise poorly absorbed
disaccharide lactulose.55 An increased L:M ratio is indicative
of a leak of lactulose across the epithelial barrier. L:M ratios,
however, can be cumbersome.56 Although altered L:M ratios
in the first 2 years of life can persist even until adulthood,57
they are subject to dynamic and geographic variations that
are both sex- and age-dependent.27 The L:M ratio also is just
one measure of small-molecule permeability rather than a
direct assessment of TJ proteins (ie, claudin-4) or barrier
modulators (ie, zonulin). Increased serum intestinal fatty-acid binding protein is a more direct marker of intestinal
injury that correlates with increased permeability. Intestinal
fatty-acid binding protein also is increased together with
activation of intestinal myeloid, B and T cells,58 and spe-
cifically fMPO.24,59,60 Impaired permeability can facilitate
microbial translocation inferred by increases in circulating
anti-lipopolysaccharide (LPS)61 or antiflagellin antibodies.62
This increased microbial translocation can promote
systemic inflammation as measured by CRP, AGP, and
kynurenine as potential markers of endogenous immune-
mediated tryptophan metabolism.24,63–65
Mucosal inflammatory markers of EED correlate with
growth restriction and enteropathogen exposures. Total
enteropathogen exposure burden is associated with
increased fMPO (as well as fecal lipocalin-2 [LCN-2] and
calprotectin [FC]). fMPO is associated most strongly with
prototypically proinflammatory pathogens (such as
Shigella/enteroinvasive E coli (EIEC) and Campylobacter
species66), but not with other pathogens that are associated
with both growth impairment and intestinal permeability
(ie, atypical enteropathogenic E coli (aEPEC), Cryptospo-
ridium,29 and Giardia67,68).69 Although enteroaggregative
Escherichia coli (EAEC), especially with fMPO, is associated
with growth impairment, L:M ratios were not altered sub-
stantially.70 In contrast, altered L:M ratios were associated
with Giardia exposure, but Giardia was associated with
decreased fMPO.67,69 Similar to the heterogeneity observed
in permeability assays,27 fMPO shows substantial within-
child variability, making individual interpretation difficult.71
Emerging metabolomics studies have shown that stunted
children show derangements in protein metabolism such as
increased endogenous conversion of tryptophan to kynur-
enine,24,72 as well as increased exogenous breakdown of
tryptophan and other aromatic amino acids (phenylalanine
and tyrosine) by intestinal microbes. Severe villus blunting,
however, may decrease systemic detection of microbial-
mediated metabolites of proteolysis.73 Muscle breakdown
products, such as creatinine,73,74 as well as microbial con-
version of choline to trimethylamine (TMA),74 also are
increased in malnourished children.
Longitudinal studies across various geographic settings
have attempted to integrate these multiple functional,
pathologic, microbial, inflammatory, and metabolic read-
outs. Although ongoing analyses provide useful insights
into complex interactions supportive of the EED paradigm, a
defined clinical panel of EED diagnostics and precise cut-off
values have yet to be determined. Furthermore, there re-
mains much uncertainty regarding which components are
sufficient, or necessary, for resulting growth impairment.
For example, in Pakistan, both gut and systemic inflamma-
tory markers correlated with linear growth restriction and
diminished insulin-like growth factor 1 (IGF-1). However,
the gut and systemic markers correlated only weakly with
one another.25 For some biomarkers, such as serum amyloid
A, diminished levels correlated with stunting at enrollment,
but increased levels at later time points are predictive of
poor linear growth.24 Increases in inflammatory markers
are not always coincident with altered permeability. Thus,
just as no microbial agent sufficiently explains EED, isolated
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whether EED exists separate from repeated enteric path-
ogen exposures is unclear. Higher-resolution prospective
epidemiologic studies to assess biomarker dynamics in
children as they relate to specific pathogen infections and
biological models therefore are attempting to disentangle
how putative pathogen exposures may result in EED, and
how resulting pathologies correspond to functional EED
sequelae, biomarkers, and interventions during early life.
Models of EED and EED-Like Conditions in Mice
Murine models of malnutrition initially characterized the
consequences of nutrient deficiency or caloric restriction
without carefully controlling for the influence of environ-
mental microbes, including pathogens, that are central to the
paradigm of EED pathogenesis.75 Likewise, conventional
pathogen challenge models in mice have been optimized for
dramatic and acute phenotypes, rather than the more indo-
lent subclinical features of EED. As in human studies, this gap
in conventional models is especially true for juvenile or
neonatal mice. New animal models are providing opportu-
nities for more mechanistic understandings of EED and EED-
like conditions (Figure 1). These models can assess intestinal
pathologic features with EED biomarkers (Supplementary
Table 1), as well as preclinical therapeutics (Table 1).
Epithelial Cell and Mucosal Defense Defects
During Defined Nutrient Deficiency
Among the various models of malnutrition in ani-
mals,76–78 isocaloric protein malnutrition (PM) alone,79 or
together with moderate fat deficiency,80,81 is epidemiologi-
cally relevant to dietary deficiencies in children with EED.11
Findings across these models were reviewed recently by
Attia et al.75 In summary, PM profoundly influences mucosal
homeostasis, but it is not sufficient to account for all fea-
tures of EED. Villus length decreases proportional to the
severity of protein deficiency.76,81,82 Some of these defects
can be restored with replenishment of alanyl-glutamine
alone.80 Moderate protein deficiency (7% protein) is suffi-
cient to alter intestinal permeability together with increases
in gene expression for tight junctions such as claudin-2,81
and decreases in TJ protein 1 (which transcribes the pro-
tein zonula occludens 1).81 However, in separate studies of
more severe protein deprivation (2% protein), immunoflu-
orescence staining of TJ proteins showed reduced occludin
but not zonula occludens 1, and no differences in claudin-2.
Claudin-3 was found to be increased along with intestinal
permeability in mice fed a moderate multinutrient-deficient
diet.80 PM also has been shown to impair intestinal
epithelial cell (IEC) proliferation as well as apoptosis, thus
impairing an often unappreciated host defense of IEC
turnover (potentially explaining the increased susceptibility
and severity of mucosal epithelial infections such as cryp-
tosporidiosis).83 Although villus blunting and altered
permeability during PM are predicted to result in dimin-
ished absorptive capacity, impaired nutrient uptake has
been difficult to prove. In contrast to PM, there is no
apparent growth restriction in mice fed a severe zinc-deficient (ZD) diet for the few weeks studied.79 Despite
clear in vitro effects on IEC membrane integrity during ZD,
alterations of intestinal architecture or barrier disruption
have not been reproduced consistently.
Disrupted architecture during early PM does not appear
to be the consequence of impaired pro-proliferative
signaling. In either protein-deprived mice or in vitro IEC
starvation models there is up-regulation of proliferative in-
testinal cell kinase, Wnt/b-catenin, mammalian target of
rapamycin, mitogen-activated protein kinase, and Akt (pro-
tein kinase B) pathways, and in response to protein depri-
vation84 apoptosis is reduced. A transient increase in Lgr5þ
stem cells suggests compensatory responses in the stem cell
niche during early time points of protein deficiency. Alter-
ations in the growth hormone and IGF-1 axis resulting from
PM could influence villus length, but have yet to be proven.85
However, altered IGF-1–receptor expression86 in apolipo-
protein E knockout mice that have accentuated malnutrition
and diminished catch-up growth upon refeeding87 suggest
that genetic determinants influence intestinal adaptations to
nutrient deprivation relevant to IGF-1 signaling.88
Undernutrition also results in changes in specialized
epithelial cells. Mucus layer depth, goblet cell numbers, and
mucus within goblet cells all are decreased, and goblet cell
differentiation might be impaired.75 These changes corre-
spond with findings of decreased mucin gene expression in
children with EED,58 however, comprehensive character-
ization of disruptions in other epithelial cell types have not
been examined thoroughly. Depriving Paneth cells of zinc
limits their function, and although some Paneth cell anti-
microbial peptides may be reduced in malnourished
adults,89 these and other specialized epithelial types have
not been scrutinized meticulously in children with EED.
Specific nutrient depletion alters baseline innate and
adaptive mucosal immune responses. Fecal markers of
epithelial cell (LCN-2) and neutrophil activation (MPO and
LCN-2) are increased in mice with PM, but not zinc deficiency
alone.79 Toll-like receptor (TLR)2 and TLR4, but not TLR9,
expression is increased during PM,90 however, TLR4 signaling
is not necessary for nutrient-dependent mucosal disruption.81
In contrast, and opposite to findings in EED, several mucosal
proinflammatory cytokines, such as IL6 and IL12p40, were
diminished in the upper small intestine during PM, whereas
IL4was increased.91 Similar to somemalnourished children,24
mice fed a protein-deficient diet also show lower serum levels
of the acute-phase reactant serum amyloid-A (L.A.B., unpub-
lished data). Changes in IL17A have been variable across
murine models (L.A.B., unpublished data). Alterations in cy-
tokines during PM correspond with an overall depletion of T
and B cells in the small intestinal lamina propria,91 but
intraepithelial lymphocytes (IELs)may be increased.81 During
either PM or ZD, CD4þ T cells are decreased disproportionally.
Importantly, the diminished lamina propria lymphocyte
numbers are fundamentally opposite of characteristic features
of EED, further suggesting environmental or pathogen con-
tributions beyond nutrient deprivation lead to EED.
Thus, dietary protein and, to a lesser extent, zinc, are
critical mediators of mucosal homeostasis, particularly in
regards to epithelial cell morphometry and function.
Figure 1. Healthy small intestine (green boxes) contrasted with intestinal pathologies observed in murine models of
nutritional deficiency alone (yellow boxes) compared with specific pathogen infection during either zinc deficiency
(pink boxes) or protein deficiency (blue boxes). *The described features are observed in models of protein deficiency. A
diminished CD4:CD8 ratio is seen during both protein and zinc deficiency. Future applications of these models can help to
address important knowledge gaps. How do genetic and epigenetic factors shape intestinal adaptations during select nutrient
deficiencies? How do microbial communities and intestinal pathogens differentially adapt to select nutrient deficiencies in the
small intestine, and what are the consequences of this altered microbial ecology on epithelial cell function, host nutrient
availability, inflammation, and metabolism? What are the consequences of nutrient and microbial-dependent acute (episodic)
and chronic (persistent) mucosal and systemic inflammation on intestinal function, susceptibility to infection, nutrient demand,
metabolism, and host growth?
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Table 1.Putative EED Therapies: Growth Outcomes in Pediatric Clinical Trials and Weaned Mouse Models
Therapeutic
Childhood EED Weaned mouse model
Undefined pathogens No pathogen EAEC ETEC Campylobacter Giardia Cryptosporidium References
Antimicrobial
Nitazoxanide Ongoinga No difference Prevents No difference No difference 92,94,120
Amixicile Improves Less severe 120
Luminal microbiota depletion
Protein deficiency No difference36–38 Improves More severe More severe More severe Prevents No difference 91
Zinc deficiency Restricts More severe Very severe Very severe 93,97,101
Targeted nutrient therapy
Alanyl-glutamine WAZ not HAZb,33 Improvesb Less severe 80,94
Arginine Less severe 123
Zinc No differenceb,32,42 No difference Restores 93
Mucosal immune modulation
TLR9 agonist (CpG) No difference Less severe 82,94
S Typhi vaccine No difference Partial recovery 82
Prior exposure Preventsc 82
Probiotic
Lactobacillus speciesd No difference43 Improves 127
aELICIT trial (NCT03268902) consisted of a combination of nitazoxanide þ azithromycin þ nicotinamide.
bIntervention either improved intestinal permeability, or prevented intestinal permeability deterioration.
cOnly intervention in which reduced intestinal pathogen burden consistently accompanied growth benefit.
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mediators (such as fMPO), the chronic intestinal inflamma-
tion of EED likely requires additional specific microbial
insults (Figure 1). It remains uncertain, however, whether
and how specific microbes, including resident microbiota,
differentially alter these host immune response adaptations
during PM.
Pathogen Susceptibility and Virulence During
Nutrient Deficiency
Many of the enteropathogens detected in stunted children
(eg, norovirus, Campylobacter species, E coli pathotypes,
Giardia, and Cryptosporidium) localize and adhere to the
small intestinal mucosa (Figure 1). Careful selection of
pathogen strains originally isolated from human beings, and
in the case of intestinal protozoa, the naturally infectious
parasite stage, have proven important for optimizing infec-
tivity and modeling features that overlap with EED. For
example, infection with the EAEC042 strain that produces a
repertoire of several virulence factors (aap, virK, aaiC, aggR)
leads to greater growth impairment compared with a strain
with more diminutive virulence gene expression.92 New
models of ETEC have show shown differential effects of heat-
labile toxin (LT) and heat-stable toxin (ST) on ETEC patho-
genesis.93 Purified Cryptosporidium parvum oocysts and
Giardia lamblia cysts aremore infectious than conventionally
used excysted Cryptosporidium sporozoites94 or axenized
Giardia trophozoites.91,95 These models have shown that PM
promotes greater small intestinal burden of intestinal path-
ogens (eg, G lamblia, w0.5 log; C parvum, w3 logs; and
EAEC042,w5 logs).91,94 Despite this increased susceptibility
to primary challenge, diminished IgA and IFNg during PM, in
the case of rotavirus96 and C parvum,82 protective host im-
mune responses against rechallenge remain surprisingly
robust. Similarly, these pathogens are of low or moderate
recurrence in children. Pathogens that frequently persist in
children, such as Giardia and EAEC, however, are capable of
prolonged colonization in even healthy fully nourished mice
if intestinal murine microbiota are depleted.95,97 In the
presence of resident microbiota, however, long-term
persistence occurs only in mice with ongoing PM.
Specific nutrients can alter virulence expression of intes-
tinal pathogens. Iron deficiency limits the pathogenicity of
invasive Salmonella infections98 and alterations in iron meta-
bolism among various E coli pathotypes differentially in-
fluences their proinflammatory potential in colitis models.99
Zinc, in contrast, diminishes EAEC042 virulence factor
expression both directly and in vivo together with enhanced
epithelial defense responses,100 whereas EAEC virulence gene
expression is increased in ZD mice.97 Zinc deficiency also
promotes ETEC virulence genes (cfa1, cexE, sta2, and degP).93
Thus, the complexity ofmicrobe–host interactions increases as
each adapts to the limited nutrient environment.
Pathogen and Host Response–Mediated
Epithelial Cell Injury
Direct pathogen-mediated epithelial cell damage is well
documented in vitro, but whether these effects aremechanistically sufficient to result in EED has yet to be
discerned. In vivo, only Campylobacter jejuni and ETEC
consistently result in diarrhea, and only when in combina-
tion with ZD and microbiota depletion.93,101 A cocktail of
E coli and Bacteroidiales mix (BG),81 Giardia,95 EAEC, or
Cryptosporidium94 can enhance villus blunting during PM,
although only Cryptosporidium leads to significant crypt
hyperplasia. In the case of E coli and Bacteroidiales81 and
Giardia (L.A.B., unpublished data), intestinal permeability is
impaired. Specific mechanisms accounting for increased
barrier permeability have not been elucidated, but alter-
ations in the TJ protein claudin-2 have been observed across
several models.81,82 Furthermore, although either Giardia or
Cryptosporidium can lead to increased IEC apoptosis in vitro
and in fully nourished animals, apoptosis as measured by
anti–cleaved caspase 3 is not increased after infection dur-
ing PM despite (and even potentially contributing to)
greater parasite burdens.83,95
These alterations in IEC homeostasis are most prominent
in the intestinal region with the greatest pathogen burden
and co-localize with mucosal cytokine responses that could
further disrupt barrier function.82,91,92 Although fully
nourished mice challenged with C parvum oocysts clear
parasites with little evidence of a secondary immune
response, even a low inoculum during PM coincides with the
early release of chemokine chemokine ligand 5, increases in
IFNg levels, and recruitment of B and T cells into the lamina
propria.82 In these studies, ongoing growth impairment
persists even after C parvum clearance and may be a
consequence of a robust influx of cytotoxic CD3þCD8þ T
cells honed to the epithelial compartment.82 Similarly,
although cytokine release from IELs in fully nourished mice
repeatedly fed the BG cocktail remained muted, BG pro-
moted tumor necrosis factor a, IFNg, and, to a lesser extent,
IL17A release in IELs of moderately malnourished mice.81
Either protein or zinc deficiency results in magnified
myeloid cell responses to EAEC042, ETEC, and Campylo-
bacter challenge,91,93,97,101 consistent with increased fMPO
in malnourished children infected with bacterial enter-
opathogen exposures.69 Thus, dysregulated proin-
flammatory cytokines and cytotoxic IELs in response to
pathogens could enhance IEC permeability. More investi-
gation is needed to determine the role of emerging innate
mucosal defense axes in EED, such as the recognition that
IL22 regulates claudin-2 to facilitate pathogen clearance.102
Pathogen-Specific Immune Responses During
Protein Malnutrition and EED
Mechanistic explanations for susceptibility to primary
and multiple enteropathogen infections in malnourished
children remain limited.103 Susceptibility appears to be
pathogen-specific. Although cryptosporidiosis is worse in
either malnourished children or mice,82 rotavirus diarrhea
may be diminished during malnutrition in children,104
neonatal piglets,77 or mice.96,105 In a cohort of Banglade-
shi infants, children with fecal biomarkers of EED (including
fMPO) showed impaired immunogenicity to oral rotavirus
and polio vaccines, but immunogenicity to parenteral vac-
cines (such as tetanus) was preserved.15 Similarly, the
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infection was amplified and memory responses to rechal-
lenge were blunted and ineffective in mice with PM.106 Diet-
dependent changes in resident microbiota during PM may
account for at least some of the increased susceptibility to
intestinal pathogens. Compared with fecal microbes from
healthy controls, gnotobiotic piglets conventionalized
with fecal microbes from children with increased fecal EED
biomarkers showed diminished rotavirus-specific IFNg-
producing T cells (mucosal, blood, and spleen), however,
neither rotavirus-specific IgA nor IgG neutralizing anti-
bodies in serum were preserved.107
Although most studies in children and mice have focused
on responses to primary infection, longitudinal rechallenge
and vaccine studies during PM in mice have shown that
despite ongoing protein deficiency, adaptive immune
responses are at least partially preserved, and can remain
pathogen-specific and protective. For example, although
a calorie-restricted diet in gnotobiotic piglets con-
ventionalized with infant microbiota impairs innate immune
responses (natural killer, plasmacytoid dendritic cells, and
CD103þ cells) and reduces serum IL12p40 in response to
primary human rotavirus challenge,78 rotavirus vaccine
efficacy in mice with PM is preserved despite diminished
fecal IgA.96 Similarly, Th1-type proinflammatory cytokines
appear globally diminished in mucosal compartments,
mesenteric lymph nodes, and spleens of mice with PM,82,91
yet select mucosal pathogen exposures can lead to sus-
tained, and in some cases may at least partially re-establish,
protective immune responses. IL17A responses to an atten-
uated oral Salmonella Typhi vaccine were preserved if not
overexuberant during PM.108 Even remote mucosal exposure
to this Salmonella Typhi vaccine vector devoid of Crypto-
sporidium antigens, or the TLR9 agonist CpG oligonucleo-
tides, led to partial attenuation of severity of weight loss after
C parvum challenge despite ongoing PM.82 Furthermore,
mice with PM show surprisingly robust protection against
both the severity and duration of C parvum shedding after
homologous rechallenge.82 Concurrent studies with G lam-
blia, however, highlight that remodeling of host immune
responses during PM is pathogen-specific. Although
Cryptosporidium leads to partial re-establishment of Th1-
type immune responses,82 Giardia magnifies an opposing
diminished Th1-type profile, despite overlapping features of
epithelial cell injury. These effects of Giardia on host re-
sponses during PM are sufficient to alter myeloid activation
in response to EAEC042 (FC and fMPO).91 In this context,
Giardia also has been found to be associated with diminished
levels of serum CRP in children109 and may be uniquely anti-
inflammatory among EED-associated pathogens.69Dysfunctional Resident Microbiota: Dysbiosis
Environmental and dietary factors increasingly are
recognized to have a profound influence on composition and
function of intestinal resident microbiota during early
childhood.110 Although there is wide geographic variation in
the 16S ribosomal RNA genomic composition of the micro-
biome of malnourished children,111,112 a longitudinalfeature of microbiome development in malnourished chil-
dren is a persistent perinatal or immature profile.113 In
weaned murine models, PM, but not ZD, results in a lag in
microbiota maturation.79 Both moderate and severe PM
regionally reshape the upper and more distal intestinal
resident microbiota composition,81,91,106 although the spe-
cific taxonomic changes are variable across laboratories.
The development of gnotobiotic models that re-
conventionalize previously germ-free mice with fecal
microbiota from malnourished children suggest that dis-
ruptions in resident microbiota are relevant for the patho-
genesis of EED. Transfer of fecal microbes from children
with kwashiorkor-type protein malnutrition into germ-free
mice show that intestinal microbiota of malnourished chil-
dren together with a nutrient-deficient diet recapitulate
metabolic perturbations resembling kwashiorkor-type
donors and concomitantly reduced growth recovery after
food supplementation, even without other EED-like changes
in the mucosa.114 Kwashiorkor-type malnutrition features,
including hypoalbuminemia, edema, and increased circu-
lating LPS, and villus blunting, also develop in calorie-
restricted gnotobiotic piglets conventionalized with fecal
microbiota even from healthy human infants. In gnotobiotic
models, the most severe phenotypes have resulted from
selective colonization with IgA-bound fecal microbiota,
consisting of members of the enterobacteriaceae family,
including E coli pathotypes, among other taxa.115 In addition
to severe weight loss, these IgA-bound microbiota promoted
crypt atrophy and epithelial cell discohesion, bacterial
translocation, andmucosal immune activation.115 In contrast,
fully nourished gnotobiotic piglets conventionalized with
fecal microbiota from children with increased EED bio-
markers did not develop histopathologic features of EED.107
In mice with moderate PM, the BG cocktail, but neither
E coli nor the Bacteroidiales members alone, or other com-
binations of intestinal microbes, led to altered villus height:-
crypt depth ratios, increased permeability, and TJ
aberrations. Thus, innovative models have established
translational links between malnutrition/EED and dysbiotic
microbial communities, although it has yet to be established
whether in the absence of nutrient deficiency such altered
microbiota alone are sufficient to recapitulate EED.
Dysbiotic microbiota and intestinal pathogens likely
interact to influence EED. Despite no apparent direct intes-
tinal pathology, the microbiota from children with EED
allowed for more severe rotavirus diarrhea in gnotobiotic
piglets.107 However, continuous depletion of resident
microbiota with antibiotics prevented Giardia-mediated
growth restriction, whereas Giardia modestly increased
bacterial load in the upper small intestine during PM.91 A
similar regimen of antibiotics given for 3 days before
EAEC042, ETEC, or Campylobacter challenge markedly
enhanced disease and allowed for up to approximately
3-log–greater peak shedding97 during zinc deficiency.93,97,101Disrupted Host-Microbial Cometabolism
EED in malnourished children is associated with per-
turbations in several host and intestinal microbial metabolic
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tine deficiency, blocked fatty acid oxidation, dysregulation of
sulfur amino acids (increased taurine and cystathionine),
increased b-aminoisobutyric acid, and decreases in hippurate,
ornithine, citrulline, and tryptophan.116–118 Conversely,
greater levels of citrulline (in girls) or tryptophan (in boys)
predicts better growth.24 Altered intestinal microbial meta-
bolism is evident by increases in microbial-dependent exog-
enous breakdown of aromatic amino acids (ie, increased
N-phenylacetylglycine and 4-hydroxyphenylacetate gluta-
mine [from phenylalanine], cresol-sulfate [from tyrosine], and
indole metabolites [from tryptophan]).118 The presence of
these metabolites, however, may be dependent in some part
on intestinal absorptive capacity.73 Increased trimethylamine
oxide (TMAO) in stunted children is indicative of increased
oxidation of microbial-mediated exogenous choline break-
down,74,79,119 and suggests potentially shared pathways with
microbial influences on the metabolic syndrome.120
In animal models, PM alone leads to expected reduction
in host catabolites of several amino acids (including
phenylalanine, valine, leucine, lysine, and ornithine). There
is also a shift toward carbohydrate metabolism seen as
increases in TCA intermediates. Microbial-derived exoge-
nous choline metabolites (methylamine, dimethylamine,
TMA, and TMAO) also are increased. However, N-
phenylacetylglycine, 4-hydroxyphenylacetate, and fatty
acid oxidation intermediates are decreased. Enteropathogen
challenges during PM show both pathogen-specific and
shared metabolic profiles that compound the effects of PM
alone. C parvum119 or EAEC infection91 further increase
TMAO, whereas TMA and TMAO are transiently decreased
after Campylobacter challenge,101 and G lamblia results in
sustained decreases in TMA and exogenous choline and
phosphatidylcholine breakdown.91 These metabolic in-
fluences of Giardia are sufficient to diminish TMA and TMAO
increases in EAEC co-infected mice. In all cases studied,
pathogens drive increased microbiota-dependent exogenous
breakdown of tryptophan, phenylalanine, and tyrosine
despite variable changes in their accompanying 16S ribo-
somal RNA profiles.83,91
Applications: Diagnostics and
Preclinical Interventions to Remediate
EED
Biomarkers of EED
Given that the majority of children with EED show no
symptoms, there is great interest in validating diagnostic
biomarkers for this subclinical condition. Broad character-
ization of phenotypes and multi-omic profiling in animal
models of EED and EED-like conditions may help identify
common pathways that could be used as diagnostic markers,
determinants of therapeutic response, or identifiers of at-risk
children before development of stunting, cognitive decline,
or metabolic syndrome.18 To date, markers of intestinal
function/barrier loss (L:M ratios, fecal a1-antitrypsin
[A1AT], fecal Reg-1, plasma zonulin), bacterial translocation
(circulating LPS or anti-LPS antibodies), intestinal inflam-
mation (fecal markers fMPO, LCN-2, lactoferrin, FC, andneopterin), systemic inflammation (serum markers CRP,
serum amyloid A, and AGP), microbial exposures (molecular-
based pathogen detections), and endocrine/metabolic
markers (growth hormone and insulin-like growth factor
1 axis) all have provided insight into EED pathogenesis, but
across multiple populations their interpretation requires
complicated expertise in biostatistics and data integration.64
For example, among children followed up in longitudinal
studies, stunting at enrollment was correlatedwith increased
circulating LPS, but poor subsequent growth is better pre-
dicted by markers of diminished absorptive/epithelial cell
function.24 In some settings, indicators of epithelial cell
injury (A1AT and Reg-1 together with plasma zonulin)
associate with poor growth only when combined with fMPO.
fMPO alone correlates with systemic inflammatory markers
(high-sensitivity C reactive protein, serum amyloid A, and
soluble CD14).24 Across several studies (including Northeast
Brazil,24 Tanzania,23 and Pakistan62), systemic inflammatory
markers and/or serum antibodies to bacterial ligands (LPS
and/or flagellin component FliC) were associated with
impaired linear growth. Although systemic markers corre-
lated with low IGF-1 and/or growth hormone resistance,
systemic inflammation does not consistently coincide with
markers of intestinal injury.24 Thus, EED may not operate
entirely through systemic inflammatory pathways, desyn-
chrony may exist between epithelial injury and resultant
chronic intestinal/systemic inflammation,25 and/or con-
founding extraintestinal inflammatory drivers also
contribute to poor childhood growth. Composite metrics
incorporating several of these markers (ie, fMPO, neopterin,
A1AT) may improve the predictability of growth impair-
ment,59 but these scoring systems remain to be validated
across multiple populations. In addition, age, sex, and dietary
factors (including amount of intake from breastfeeding) can
confound several of these assays.60,71
In animal models, temporal relationships between a
defined exposure to a putative EED trigger and/or nutrient
deficiency and these or other biomarkers are being char-
acterized, but mechanisms accounting for resulting growth
impairment, such as persistent systemic inflammation even
after intestinal restitution, have not yet been elucidated.Preclinical Therapeutics
Antimicrobial, nutritional, immune-mediated, and pro-
biotic interventions in EED models can provide insights into
potential novel therapeutics (Table 1). Nitazoxanide, a
Pyruvate:ferredoxin oxidoreductase antagonist with anti-
anaerobic and antiparasitic properties, can partially rescue
EAEC042 infection during moderate PM, but nitazoxanide is
ineffective at reducing the severity of cryptosporidiosis.92,94
Amixicile, however, a water-soluble nitazoxanide derivative
that lacks anticryptosporidial activity, can benefit the
growth of mice with PM even after C parvum challenge.121
Depletion of resident microbiota has differential effects
depending on the specific pathogen challenge. Oral replen-
ishment of specific amino acids (such as alanyl-glutamine)
can support IEC proliferation and partially restore host
growth,80 even during Cryptosporidium challenge.94
2019 Modeling Environmental Enteric Dysfunction 701Interestingly, the full benefit of alanyl-glutamine may
depend on combining treatment with targeted antibiotics
and/or modulators to reduce overexuberant host inflam-
mation.122,123 Parenteral delivery of arginine also can
attenuate the intensity of Cryptosporidium infection and the
severity of growth impairment in undernourished mice
through pathways of both defense-promoting induction of
nitric oxide as well as arginase pathways important for IEC
restitution.124 Tryptophan increased systemic and mucosal
T-regulatory cell numbers in both nutrient-deficient and
-sufficient piglets,125 however, tryptophan may worsen
certain infections,126 including Cryptosporidium during
protein malnutrition (D.T.B. and R.L.G., unpublished data).
Intestinal microbiota from healthy donors can strikingly
restore growth and metabolic function during multinutrient
malnutrition,127 and even some specific taxa (ie, Lactoba-
cillus plantarumWJL)128 may be sufficient to promote growth
despite diminished nutritional intake. Co-colonization with
Akkermansia mucinophila and C scindens isolated from
stools of healthy child controls was able to mitigate the
deleterious effects of the IgA-bound enterobacteriaceae.115
Emerging Models and Reductionist Systems
In addition to murine models, advances in human orga-
noid systems for the study of intestinal pathogens is rapidly
expanding.129–131 Extension of findings in murine models
into these and other systems (ie, humanized mice, human-
derived enteroids, organoids, and gut/organ-on-a-chip
technologies) will be critical for validation and to over-
come notable limitations in translating animal models to
human disease. Such models also can represent powerful
new tools to elucidate pathways by which EED therapies
may restore gut healing.132
Conclusions
It is clear that our understanding of the complexities
driving EED remains superficial at best. Comparisons and
contrasts between findings in these early EED models and
ongoing studies in child cohorts suggest that EED may be a
heterogenous condition, resulting from a convergence of
dynamic microbial and nutritional factors that may be either
episodic or persistent, and result in lingering disruptions
even after the primary insult has cleared. Until these dis-
eases other than overt diarrhea are named, they remain
inadequately counted and are overlooked in key analyses of
the impact or of the effectiveness of preventive or thera-
peutic interventions. Therefore, we have suggested 3
respective names for 3 major EED disease outcomes as:
HAZdrop (for the reductions in HAZ scores in the first 2
years of life), COG-hit (for the cognitive impairment hit of
normal cognitive development attributable to early child-
hood enteropathy), and MET-syn (for the later-life metabolic
syndrome that is being appreciated as increased in those
who had experienced early childhood enteric infections.14,17
As sequelae of EED beyond growth restriction emerge,
applying EED models to identify specific microbe–microbe
and microbe–host interactions that can sustain mucosal
health and defense, promote intestinal restitution, preservephysical and cognitive development, and avert metabolic
syndrome becomes increasingly important for improving
the health of children around the globe.References
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